Weekly Updates

Illustration of inhaled itraconazole being delivered into the lungs as a potential treatment for ABPA

Aspergillosis Weekly Research Update

Aspergillosis research update infographic summarising July 2026 studies on invasive aspergillosis, isavuconazole, macrophages and tuberculosis.

Aspergillosis Research Update: ICU Infections, Immune Defences and Antifungal Treatment

Infographic summarising the July 2026 weekly aspergillosis research update, highlighting new COPD diagnostic criteria for invasive pulmonary aspergillosis, chronic pulmonary aspergillosis serology, ICU galactomannan testing, environmental prevention of fungal disease, and other key research developments.

Weekly Aspergillosis Research Update: COPD IPA Criteria, CPA Serology, ICU Galactomannan and Environmental Prevention

Illustration summarising new research showing allergic bronchopulmonary aspergillosis (ABPA) and Aspergillus sensitisation may be more common in people with chronic obstructive pulmonary disease (COPD).

Weekly Aspergillosis Research Update: June 29

Medical illustration showing Aspergillus fumigatus, PCR diagnostics, lung imaging, antifungal medicines and laboratory research representing recent advances in aspergillosis diagnosis, treatment and antifungal resistance research.

Weekly Aspergillosis Research Update: New Diagnostics, CAPA Evidence, and Why Azole Tolerance Matters

Infographic summarising June 2026 aspergillosis research including tuberculosis-related chronic pulmonary aspergillosis risk, fungal ball biology, ABPA, advanced diagnostics and emerging immunotherapies.

Weekly Aspergillosis Research Update – 15 June 2026

Scientific illustration showing Aspergillus research, antifungal susceptibility testing, therapeutic drug monitoring and clinical management featured in the May 2026 Professional Aspergillosis Update.

Professional Aspergillosis Update: May 2026

Audience: respiratory…

Respiratory specialist discussing lung scan results with a patient, illustrating diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA), Chronic Pulmonary Aspergillosis (CPA), eosinophils, IgE testing, antifungal treatment and home monitoring.

Aspergillosis Research Update: Week Ending 8 June 2026

Key Points This was a…

Illustration showing recent aspergillosis research advances including improved diagnostics, ABPA risk factors, chronic pulmonary aspergillosis testing, immune therapies and patient-centred care.

Aspergillosis Research Update: Earlier Diagnosis, Better Testing and New Treatment Possibilities

Person reading a patient-friendly aspergillosis research update with lung, laboratory and fungal research illustrations.

Weekly Aspergillosis Research Update 18th May 2026

In this week’s aspergillosis…